Literature DB >> 32599675

Copper homeostasis: Emerging target for cancer treatment.

Yueqin Li1.   

Abstract

Copper (Cu) is an essential micronutrient involved in a variety of fundamental biological processes. Recently, disorder of Cu homeostasis can be observed in many malignancies. Elevated Cu levels in serum and tissue are correlated with cancer progression. Hence, targeting Cu has emerged as a novel strategy in cancer treatment. This review provides an overview of physiological Cu metabolism and its homeostasis, followed by a discussion of the dysregulation of Cu homeostasis in cancer and the effects of Cu on cancer progression. Finally, recent therapeutic advances using Cu coordination complexes as anticancer agents, as well as the mechanisms of their anti-cancer action are discussed. This review contributes full comprehension to the role of Cu in cancer and demonstrates the broad application prospect of Cu coordination compounds as potential therapeutic agents.
© 2020 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cancer treatment; copper chelators; copper homeostasis; copper ionophores

Year:  2020        PMID: 32599675     DOI: 10.1002/iub.2341

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  16 in total

1.  Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma.

Authors:  Qiongyue Zhang; Yan Huang; Yu Xia; Yumeng Liu; Jianhe Gan
Journal:  Clin Exp Med       Date:  2022-09-24       Impact factor: 5.057

2.  Downregulated Copper Homeostasis-Related Gene FOXO1 as a Novel Indicator for the Prognosis and Immune Response of Breast Cancer.

Authors:  Rong Zeng; Bi Peng; Emin Peng
Journal:  J Immunol Res       Date:  2022-06-28       Impact factor: 4.493

Review 3.  The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.

Authors:  Priti Tagde; Pooja Tagde; Fahadul Islam; Sandeep Tagde; Muddaser Shah; Zareen Delawar Hussain; Md Habibur Rahman; Agnieszka Najda; Ibtesam S Alanazi; Mousa O Germoush; Hanan R H Mohamed; Mardi M Algandaby; Mohammed Z Nasrullah; Natalia Kot; Mohamed M Abdel-Daim
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

Review 4.  Minerals and Cancer: Overview of the Possible Diagnostic Value.

Authors:  Sascha Venturelli; Christian Leischner; Thomas Helling; Olga Renner; Markus Burkard; Luigi Marongiu
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

Review 5.  Selective Targeting of Cancer Cells by Copper Ionophores: An Overview.

Authors:  Valentina Oliveri
Journal:  Front Mol Biosci       Date:  2022-03-04

6.  Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma.

Authors:  Zhen Zhang; Xiangyang Zeng; Yinghua Wu; Yang Liu; Xi Zhang; Zewen Song
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

7.  Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.

Authors:  Shengxian Xu; Dongze Liu; Taihao Chang; Xiaodong Wen; Shenfei Ma; Guangyu Sun; Longbin Wang; Shuaiqi Chen; Yong Xu; Hongtuan Zhang
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

Review 8.  Evidence of Metallic and Polyether Ionophores as Potent Therapeutic Drug Candidate in Cancer Management.

Authors:  Pratibha Pandey; Fahad Khan; Huda A Qari; Tarun Kumar Upadhyay; Abdulhameed F Alkhateeb; Mohammad Oves
Journal:  Molecules       Date:  2022-07-23       Impact factor: 4.927

9.  Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas.

Authors:  Shouyi Tang; Li Zhao; Xing-Bo Wu; Zhen Wang; Lu-Yao Cai; Dan Pan; Ying Li; Yu Zhou; Yingqiang Shen
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

10.  The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration.

Authors:  Xu Wang; Mingzhi Han; Songyu Chen; Yanfei Sun; Ruirong Tan; Bin Huang
Journal:  Front Cell Neurosci       Date:  2022-08-18       Impact factor: 6.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.